Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07316166 · ClinicalTrials.gov registry record · Phase 4
Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine
A Phase 4 study of Postoperative Pain Management, sponsored by Rhode Island Hospital.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07316166: Recruiting Phase 4 study of Postoperative Pain Management, sponsored by Rhode Island Hospital.
NCT07316166 is a Phase 4 study of Postoperative Pain Management that is actively recruiting participants, run by Rhode Island Hospital. The registered enrollment target is 120 participants, roughly in line with the 123-participant average among 7 other Postoperative Pain Management trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07316166, a Phase 4 study of Postoperative Pain Management, is actively recruiting participants, sponsored by Rhode Island Hospital.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are evaluating postoperative outcomes in patients undergoing hip replacement surgery performed with either spinal or general anesthesia, who also receive a suprainguinal fascia iliaca block using either perineural ropivacaine alone or ropivacaine combined with dexmedetomidine.
Conditions Studied
Interventions
- DRUG Dexmedetomidine
- DRUG Ropivacaine
Study Locations (1)
Rhode Island
- The Miriam Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-12-08 |
| Est. Completion | 2027-06 |
| Phase | Phase 4 |
What NCT07316166 shows while recruiting
NCT07316166 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 123-participant average among 7 other Postoperative Pain Management trials with a reported enrollment target.
The record links to 1 condition, with Postoperative Pain Management appearing as the primary indexed condition, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT07316166 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT07316166 about?
NCT07316166 is a clinical study titled "Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine". The investigators are evaluating postoperative outcomes in patients undergoing hip replacement surgery performed with either spinal or general anesthesia, who also receive a suprainguinal fascia iliaca block using either perineural ropivacaine alone or ropivacaine combined with dexmedetomidine.
What is the current status of trial NCT07316166?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2025-12-08. Estimated completion is 2027-06.
What conditions does trial NCT07316166 study?
This clinical trial studies the following conditions: Postoperative Pain Management.
What interventions are being tested in trial NCT07316166?
The interventions under investigation include: Dexmedetomidine (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT07316166?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07316166 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain Management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Magnesium and Cramping
RECRUITING · Phase 4
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery
RECRUITING · NA
-
Impact of Nd:YAG Laser Photobiostimulation on Healing of Gingiva
RECRUITING · NA
-
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
RECRUITING · NA
-
Combined Cryotherapy With Compression Versus Cryotherapy Alone After Orthopaedic Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI